Comparison of WHO Classifications (2004,2010), the Hochwald Grading System, and AJCC and ENETS Staging Systems in Predicting Prognosis in Locoregional Well-differentiated Pancreatic Neuroendocrine Tumors

被引:64
作者
Liu, Ta-Chiang [1 ]
Hamilton, Nicholas [2 ]
Hawkins, William [2 ]
Gao, Feng [3 ]
Cao, Dengfeng [1 ,4 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[2] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[4] Peking Univ, Canc Hosp & Inst, Minist Educ,Dept Pathol, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China
关键词
pancreatic neuroendocrine tumor; WHO classification; AJCC staging; ENETS staging; Hochwald grading system; Ki-67 proliferation index; ENDOCRINE NEOPLASMS; PROTEIN; PROPOSAL; INDEX; MEN1;
D O I
10.1097/PAS.0b013e31827fcc18
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
It is difficult to predict prognosis in patients with locoregional well-differentiated (WD) pancreatic neuroendocrine tumors (PanNET). We aimed to examine commonly used stratification systems [World Health organization (WHO) 2004 and 2010 classifications, American Joint Committee on Cancer (AJCC) and European Neuroendocrine Tumor Society (ENETS) staging, and the Hochwald grading system] for their power in predicting recurrence-free survival (RFS) in these patients. Seventy-five such patients (mean age 56 y, mean follow-up 79 mo) who underwent resection with sufficient tissue material and follow-up data were studied. RFS was correlated with variable clinicopathologic features and stratified with above-mentioned systems. Concordance index (CI) was then calculated. With the WHO 2004 classification, 16, 35, and 24 PanNETs were classified as benign behavior, uncertain behavior, and WD endocrine carcinoma, respectively. By the WHO 2010 classification, 26, 41, and 8 tumors were grade 1, 2, and 3, respectively. Using the Hochwald system, 47 were low grade, and 28 were intermediate grade. The AJCC staging information was complete for 62 patients (13 had the lymph node status Nx) and included: stages IA (19/62), IB (10/62), IIA (10/62), and IIB (23/62). The ENETS staging information was stages I (16/62), IIa (8/62), IIb (14/62), IIIa (0/62), and IIIb (24/62). The average Ki-67 proliferation index (PI) was 8.1%. Factors that predicted RFS included tumor size, nodal metastasis, vascular invasion, perineural invasion, necrosis, mitosis, and Ki-67 PI (all P < 0.01). The CI for each system was: 0.6361 for WHO 2004, 0.6735 for WHO 2010, 0.6495 for AJCC staging, 0.6642 for ENETS staging, and 0.6851 for the Hochwald grading system. When these systems were analyzed in conjunction with various additional important pathologic features, combination of the Hochwald grading system and Ki-67 PI achieved the highest CI (0.7946). Therefore, although all these systems predict RFS well in locoregional WD PanNETs, the Hochwald grading system achieves the highest predictive ability. Further predictive power can be achieved by combining the Hochwald grading system and Ki-67 PI.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 24 条
[1]   Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome [J].
Anlauf, M ;
Schlenger, R ;
Perren, A ;
Bauersfeld, J ;
Koch, CA ;
Dralle, H ;
Raffel, A ;
Knoefel, WT ;
Weihe, E ;
Ruszniewski, P ;
Couvelard, A ;
Komminoth, P ;
Heitz, PU ;
Klöppel, G .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (05) :560-574
[2]  
[Anonymous], 2004, PATHOLOGY GENETICS T
[3]  
[Anonymous], EXOCRINE ENDOCRINE P
[4]   MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases [J].
Corbo, Vincenzo ;
Dalai, Irene ;
Scardoni, Maria ;
Barbi, Stefano ;
Beghelli, Stefania ;
Bersani, Samantha ;
Albarello, Luca ;
Doglioni, Claudio ;
Schott, Christina ;
Capelli, Paola ;
Chilosi, Marco ;
Boninsegna, Letizia ;
Becker, Karl-Friedrich ;
Falconi, Massimo ;
Scarpa, Aldo .
ENDOCRINE-RELATED CANCER, 2010, 17 (03) :771-783
[5]   Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy [J].
de Wilde, Roeland F. ;
Edil, Barish H. ;
Hruban, Ralph H. ;
Maitra, Anirban .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (04) :199-208
[6]   Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? [J].
Ferrone, Cristina R. ;
Tang, Laura H. ;
Tomlinson, James ;
Gonen, Mithat ;
Hochwald, Steven N. ;
Brennan, Murray F. ;
Klimstra, David S. ;
Allen, Peter J. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (35) :5609-5615
[7]   Comparison of Methods for Proliferative Index Analysis for Grading Pancreatic Well-Differentiated Neuroendocrine Tumors [J].
Goodell, Pamela P. ;
Krasinskas, Alyssa M. ;
Davison, Jon M. ;
Hartman, Douglas J. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (04) :576-582
[8]   Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors [J].
Halfdanarson, Thorvardur R. ;
Rubin, Joseph ;
Farnell, Michael B. ;
Grant, Clive S. ;
Petersen, Gloria M. .
ENDOCRINE-RELATED CANCER, 2008, 15 (02) :409-427
[9]   Altered Telomeres in Tumors with ATRX and DAXX Mutations [J].
Heaphy, Christopher M. ;
de Wilde, Roeland F. ;
Jiao, Yuchen ;
Klein, Alison P. ;
Edil, Barish H. ;
Shi, Chanjuan ;
Bettegowda, Chetan ;
Rodriguez, Fausto J. ;
Eberhart, Charles G. ;
Hebbar, Sachidanand ;
Offerhaus, G. Johan ;
McLendon, Roger ;
Rasheed, B. Ahmed ;
He, Yiping ;
Yan, Hai ;
Bigner, Darell D. ;
Oba-Shinjo, Sueli Mieko ;
Marie, Suely Kazue Nagahashi ;
Riggins, Gregory J. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Hruban, Ralph H. ;
Maitra, Anirban ;
Papadopoulos, Nickolas ;
Meeker, Alan K. .
SCIENCE, 2011, 333 (6041) :425-425
[10]   Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups [J].
Hochwald, SN ;
Zee, S ;
Conlon, KC ;
Colleoni, R ;
Louie, O ;
Brennan, MF ;
Klimstra, DS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2633-2642